T2 Biosystems, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Craig R. Jalbert
IPO Date
2014-08-07
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.15
Market Cap
$0.00B
Volume
0.00M
| -0.1 |
| 31 Dec 2021 | FY | 26.2% | -175.5% | 381.6% | -81.3% | -4.52 | 3.80 | -1.7 |
| 31 Dec 2020 | FY | -17.4% | -258.1% | -536.3% | -59.2% | 6.52 | 5.47 | -3.2 |
| 31 Dec 2019 | FY | -101.1% | -707.9% | 173.5% | -207.1% | -1.32 | 0.31 | -0.9 |
| 31 Dec 2018 | FY | -46.7% | -487.2% | -449.2% | -79.5% | 3.79 | 1.08 | -119.3 |
| 31 Dec 2017 | FY | -157.8% | -1337.9% | -4658.8% | -113.8% | 31.85 | 0.86 | -106.0 |
| 31 Dec 2016 | FY | -68.4% | -1343.2% | -139.3% | -61.2% | 1.06 | 7.63 | -124.8 |
| 31 Dec 2015 | FY | 38.1% | -1610.0% | -96.5% | -52.1% | 0.68 | 6.16 | -247.6 |
| 31 Dec 2014 | FY | -16523.5% | -26378.2% | -59.2% | -39.8% | 0.40 | 15.50 | -265.9 |
| -2.1 |
| 31 Mar 2024 | Q1 | -103.9% | -656.7% | 35.8% | -54.7% | -1.31 | 0.28 | -0.3 |
| 31 Dec 2023 | Q4 | -57.7% | -615.8% | 36.9% | -29.7% | -1.77 | 0.45 | -0.8 |
| 30 Sept 2023 | Q3 | -166.6% | -1047.9% | 80.2% | -35.6% | -2.57 | 0.59 | -1.6 |
| 30 Jun 2023 | Q2 | -147.9% | -323.2% | 17.4% | -17.1% | -1.63 | 0.36 | -0.2 |
| 31 Mar 2023 | Q1 | -92.3% | -864.5% | 36.0% | -54.9% | -1.19 | 1.06 | -0.1 |
| 31 Dec 2022 | Q4 | 32.0% | -184.2% | 25.5% | -29.4% | -1.49 | 1.91 | -0.3 |
| 30 Sept 2022 | Q3 | -65.5% | -515.4% | 59.8% | -43.1% | -1.86 | 2.64 | -0.4 |
| 30 Jun 2022 | Q2 | 14.0% | -356.1% | 56.1% | -53.1% | -1.56 | 1.87 | -0.3 |